These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9750080)
1. Butyrolactone-induced central nervous system depression after ingestion of RenewTrient, a "dietary supplement". LoVecchio F; Curry SC; Bagnasco T N Engl J Med; 1998 Sep; 339(12):847-8. PubMed ID: 9750080 [No Abstract] [Full Text] [Related]
2. Central nervous system depression after ingestion of RenewTrient. Olson KR; Dyer JE; Haller C N Engl J Med; 1999 Feb; 340(7):570. PubMed ID: 10026060 [No Abstract] [Full Text] [Related]
3. Central nervous system depression after ingestion of RenewTrient. Nelson LS; Howland MA; Hoffman RS N Engl J Med; 1999 Feb; 340(7):570. PubMed ID: 10026059 [No Abstract] [Full Text] [Related]
5. A safety trial of sodium oxybate in patients with obstructive sleep apnea: Acute effects on sleep-disordered breathing. George CF; Feldman N; Inhaber N; Steininger TL; Grzeschik SM; Lai C; Zheng Y Sleep Med; 2010 Jan; 11(1):38-42. PubMed ID: 19897413 [TBL] [Abstract][Full Text] [Related]
6. Rigorous study of Xyrem®/sodium oxybate use among patients with obstructive sleep apnea and other conditions of compromised respiratory function is critically needed. Zvosec DL; Smith SW; Mahowald MW Sleep Med; 2011 Jan; 12(1):103-4; author reply 104-5. PubMed ID: 20643578 [No Abstract] [Full Text] [Related]
7. Sodium oxybate and modafinil: a good combination? Ortega-Albás JJ; López-Bernabé R; Serrano AL; Díaz JR Sleep Med; 2010 Oct; 11(9):957. PubMed ID: 20643579 [No Abstract] [Full Text] [Related]
8. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies. McDaniel CH; Miotto KA J Psychoactive Drugs; 2001; 33(2):143-9. PubMed ID: 11476261 [TBL] [Abstract][Full Text] [Related]
10. The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans. Bosch OG; Seifritz E Brain Res Bull; 2016 Sep; 126(Pt 1):47-60. PubMed ID: 26855327 [TBL] [Abstract][Full Text] [Related]
11. Severe central nervous and respiratory system depression after sedation with chloral hydrate: a case report. Ceçen E; Uygur O; Tosun A Turk J Pediatr; 2009; 51(5):497-9. PubMed ID: 20112608 [TBL] [Abstract][Full Text] [Related]
12. Some neurochemical aspects of the depressant action of gamma-butyrolactone on the central nervous system. GIARMAN NJ; SCHMIDT KF Br J Pharmacol Chemother; 1963 Jun; 20(3):563-8. PubMed ID: 13947640 [TBL] [Abstract][Full Text] [Related]
13. Sudden leg paralysis in a 26-year-old nurse. Ulrich S; Müller V; Keel M; Seebach JD Swiss Med Wkly; 2005 Apr; 135(13-14):206; author reply 206-7. PubMed ID: 15909238 [No Abstract] [Full Text] [Related]
14. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention. Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314 [TBL] [Abstract][Full Text] [Related]
15. [Clinical pharmacology of narcotics and sedatives]. Lange G Z Allgemeinmed; 1971 Dec; 47(35):1846-52. PubMed ID: 4332993 [No Abstract] [Full Text] [Related]
16. Adverse events, including death, associated with the use of 1,4-butanediol. Zvosec DL; Smith SW; McCutcheon JR; Spillane J; Hall BJ; Peacock EA N Engl J Med; 2001 Jan; 344(2):87-94. PubMed ID: 11150358 [TBL] [Abstract][Full Text] [Related]
17. [Effect of triterpene glycosides of Patrinia intermedia Roem. et Schult on the central nervous system]. Lapik AS; Bukharov VG; Talan VA; Karlin VV Farmakol Toksikol; 1968; 31(6):650-2. PubMed ID: 5713574 [No Abstract] [Full Text] [Related]